Cargando…

Molecular mechanisms of the preventable causes of cancer in the United States

Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer deaths in the United States alone. The public health burden associated with these numbers has motivated enormous research efforts into understanding the root causes of cancer. These efforts have led to the recognition that...

Descripción completa

Detalles Bibliográficos
Autores principales: Golemis, Erica A., Scheet, Paul, Beck, Tim N., Scolnick, Eward M., Hunter, David J., Hawk, Ernest, Hopkins, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075032/
https://www.ncbi.nlm.nih.gov/pubmed/29945886
http://dx.doi.org/10.1101/gad.314849.118
_version_ 1783344528396124160
author Golemis, Erica A.
Scheet, Paul
Beck, Tim N.
Scolnick, Eward M.
Hunter, David J.
Hawk, Ernest
Hopkins, Nancy
author_facet Golemis, Erica A.
Scheet, Paul
Beck, Tim N.
Scolnick, Eward M.
Hunter, David J.
Hawk, Ernest
Hopkins, Nancy
author_sort Golemis, Erica A.
collection PubMed
description Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer deaths in the United States alone. The public health burden associated with these numbers has motivated enormous research efforts into understanding the root causes of cancer. These efforts have led to the recognition that between 40% and 45% of cancers are associated with preventable risk factors and, importantly, have identified specific molecular mechanisms by which these exposures modify human physiology to induce or promote cancer. The increasingly refined knowledge of these mechanisms, which we summarize here, emphasizes the need for greater efforts toward primary cancer prevention through mitigation of modifiable risk factors. It also suggests exploitable avenues for improved secondary prevention (which includes the development of therapeutics designed for cancer interception and enhanced techniques for noninvasive screening and early detection) based on detailed knowledge of early neoplastic pathobiology. Such efforts would complement the current emphasis on the development of therapeutic approaches to treat established cancers and are likely to result in far greater gains in reducing morbidity and mortality.
format Online
Article
Text
id pubmed-6075032
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-60750322018-08-16 Molecular mechanisms of the preventable causes of cancer in the United States Golemis, Erica A. Scheet, Paul Beck, Tim N. Scolnick, Eward M. Hunter, David J. Hawk, Ernest Hopkins, Nancy Genes Dev Review Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer deaths in the United States alone. The public health burden associated with these numbers has motivated enormous research efforts into understanding the root causes of cancer. These efforts have led to the recognition that between 40% and 45% of cancers are associated with preventable risk factors and, importantly, have identified specific molecular mechanisms by which these exposures modify human physiology to induce or promote cancer. The increasingly refined knowledge of these mechanisms, which we summarize here, emphasizes the need for greater efforts toward primary cancer prevention through mitigation of modifiable risk factors. It also suggests exploitable avenues for improved secondary prevention (which includes the development of therapeutics designed for cancer interception and enhanced techniques for noninvasive screening and early detection) based on detailed knowledge of early neoplastic pathobiology. Such efforts would complement the current emphasis on the development of therapeutic approaches to treat established cancers and are likely to result in far greater gains in reducing morbidity and mortality. Cold Spring Harbor Laboratory Press 2018-07-01 /pmc/articles/PMC6075032/ /pubmed/29945886 http://dx.doi.org/10.1101/gad.314849.118 Text en © 2018 Golemis et al.; Published by Cold Spring Harbor Laboratory Press http://creativecommons.org/licenses/by/4.0/ This article, published in Genes & Development, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Golemis, Erica A.
Scheet, Paul
Beck, Tim N.
Scolnick, Eward M.
Hunter, David J.
Hawk, Ernest
Hopkins, Nancy
Molecular mechanisms of the preventable causes of cancer in the United States
title Molecular mechanisms of the preventable causes of cancer in the United States
title_full Molecular mechanisms of the preventable causes of cancer in the United States
title_fullStr Molecular mechanisms of the preventable causes of cancer in the United States
title_full_unstemmed Molecular mechanisms of the preventable causes of cancer in the United States
title_short Molecular mechanisms of the preventable causes of cancer in the United States
title_sort molecular mechanisms of the preventable causes of cancer in the united states
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075032/
https://www.ncbi.nlm.nih.gov/pubmed/29945886
http://dx.doi.org/10.1101/gad.314849.118
work_keys_str_mv AT golemisericaa molecularmechanismsofthepreventablecausesofcancerintheunitedstates
AT scheetpaul molecularmechanismsofthepreventablecausesofcancerintheunitedstates
AT becktimn molecularmechanismsofthepreventablecausesofcancerintheunitedstates
AT scolnickewardm molecularmechanismsofthepreventablecausesofcancerintheunitedstates
AT hunterdavidj molecularmechanismsofthepreventablecausesofcancerintheunitedstates
AT hawkernest molecularmechanismsofthepreventablecausesofcancerintheunitedstates
AT hopkinsnancy molecularmechanismsofthepreventablecausesofcancerintheunitedstates